相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition
Shinji Saiki et al.
AUTOPHAGY (2011)
HDL and Sphingosine-1-Phosphate Activate Stat3 in Prostate Cancer DU145 Cells Via ERK1/2 and S1P Receptors, and Promote Cell Migration and Invasion
Yoshitaka Sekine et al.
PROSTATE (2011)
Myriocin-mediated up-regulation of hepatocyte apoA-I synthesis is associated with ERK inhibition
Elias N. Glaros et al.
CLINICAL SCIENCE (2010)
Ganglioside GD3 Enhances Adhesion Signals and Augments Malignant Properties of Melanoma Cells by Recruiting Integrins to Glycolipid-enriched Microdomains
Yuki Ohkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Determination of Myriocin in Natural and Cultured Cordyceps cicadae Using 9-Fluorenylmethyl Chloroformate Derivatization and High-Performance Liquid Chromatography with UV-Detection
Jiawen Yu et al.
ANALYTICAL SCIENCES (2009)
Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells
Maria L. Watson et al.
BIOCHEMICAL JOURNAL (2009)
Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway
Jun-ichi Okano et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2008)
Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer
Harikrishna Devalapally et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Inhibition of atherosclerosis by the serine palmitoyl transferase inhibitor myriocin is associated with reduced plasma glycosphingolipid concentration
Elias N. Glaros et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Caffeine promotes apoptosis in mitotic spindle checkpoint-arrested cells
Brian Gabrielli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Melanoma biology and new targeted therapy
Vanessa Gray-Schopfer et al.
NATURE (2007)
The clinical potential of sphingolipid-based therapeutics
T. E. Fox et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Strategies for the development of more effective adjuvant therapy of melanoma: Current and future explorations of antibodies, cytokines, vaccines, and combinations
JM Kirkwood et al.
CLINICAL CANCER RESEARCH (2006)
Sphingolipid targets in cancer therapy
DE Modrak et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The Ras/Raf/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma
F Meier et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2005)
Development of cell cycle active drugs for the treatment of gastrointestinal cancers: A new approach to cancer therapy
GK Schwartz
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice
MR Hojjati et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sphingolipid metabolism enzymes as targets for anticancer therapy
JW Kok et al.
CURRENT DRUG TARGETS (2004)
Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression
DC Fingar et al.
ONCOGENE (2004)
Ceramide synthesis and metabolism as a target for cancer therapy
CP Reynolds et al.
CANCER LETTERS (2004)
Ceramide 1-phosphate is a direct activator of cytosolic phospholipase A2
BJ Pettus et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Biologically active sphingolipids in cancer pathogenesis and treatment
B Ogretmen et al.
NATURE REVIEWS CANCER (2004)
The complex life of simple sphingolipids
AH Futerman et al.
EMBO REPORTS (2004)
Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatasel
JK Min et al.
ANALYTICAL BIOCHEMISTRY (2002)
Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide the A549 human lung adenocarcinoma cell line - Role for endogenous ceramide in mediating the action of exogenous ceramide
B Ogretmen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
P53 mediates ceramide-induced apoptosis in SKN-SH cells
SS Kim et al.
ONCOGENE (2002)
Drug-resistance in human melanoma
H Helmbach et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Regulation of the G2/M transition by p53
WR Taylor et al.
ONCOGENE (2001)
Inactivation of the apoptosis effector Apaf-1 in malignant melanoma
MS Soengas et al.
NATURE (2001)
分享论文
